Zimmer Biomet Holdings, Inc. (ZBH) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zimmer Biomet Holdings, Inc. (ZBH:NYSE), powered by AI.
- Current Price
- $89.33
- P/E Ratio
- 25.1
- Market Cap
- 17.7B
- Sector
- Healthcare
What is the Zimmer Biomet Holdings, Inc. stock price forecast?
Zimmer Biomet Holdings, Inc. is currently trading at $89.33. View real-time AI analysis on Alpha Lenz.
What is Zimmer Biomet Holdings, Inc. insider trading activity?
View the latest insider trading data for Zimmer Biomet Holdings, Inc. on Alpha Lenz.
What is Zimmer Biomet Holdings, Inc.'s P/E ratio?
Zimmer Biomet Holdings, Inc.'s P/E ratio is 25.1.
Zimmer Biomet Holdings, Inc.
NYSE · ZBH“Zimmer Biomet Holdings, Inc. trades at a P/E of 25.1 (premium valuation) with modest ROE of 5.6%.”
Ask for details →Company Overview
Zimmer Biomet Holdings, Inc. is a leading global medical technology company specializing in the design, manufacture, and marketing of orthopedic reconstructive products. Its portfolio encompasses knee and hip implants, sports medicine solutions, biologics, trauma devices, and extremities products, as well as craniomaxillofacial and thoracic offerings for facial and chest reconstruction. Zimmer Biomet also integrates advanced digital and robotic technologies, artificial intelligence tools, and surgical instruments to enhance mobility and support joint and bone health. The company serves a diverse array of healthcare professionals—including orthopedic surgeons, neurosurgeons, and hospital systems—with products aimed at improving the quality of life for patients with musculoskeletal disorders and injuries. Established in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet operates across the Americas, Europe, Asia-Pacific, the Middle East, and Africa, reinforcing its significant role in the healthcare sector by continuously advancing musculoskeletal care and surgical innovation.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Zimmer Biomet Holdings, Inc. trades at a P/E of 25.1 (premium valuation) with modest ROE of 5.6%.”
Ask for details →Frequently Asked Questions
Zimmer Biomet Holdings, Inc. (ticker: ZBH) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 17,000 employees. Market cap is $17.7B.
The current price is $89.33 with a P/E ratio of 25.08x and P/B of 1.39x.
ROE is 5.60% and operating margin is 16.48%. Annual revenue is $8.2B.